• remove Biosafety Level: *

New Products

  • ATCC Screening Fee (ATCC® ACS-2103)

    ATCC® Number: ACS-2103
    Applications:

    For commercial accounts, this cell line is only distributed under the terms of a fully signed and executed ATCC® Material Transfer Agreement and Addendum.  If the commercial account is screening per completed Addendum, the recipient will be required to pay a Screening Fee (ATCC® ACS-2103) of $4000.00. 

    Screening Use is defined as use of Biological Material in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development.

    If the commercial account is not screening per the completed Addendum, the recipient will not be required to pay a Screening Fee.

    For-Profit:   $4,000.00 Non-Profit:   $4,000.00

    Preview Product

  • Neural Progenitor Cell Dopaminergic Differentiation Kit (ATCC® ACS-3004)

    ATCC® Number: ACS-3004
    Applications:

    The media is specially designed for the dopaminergic differentiation of iPSC-derived neural progenitor cells (NPCs).

    Complete dopaminergic differentiation medium for NPCs is DMEM: F12 (ATCC® 30-2006; not included) supplemented with the Growth Kit for Neural Progenitor Cell Expansion (ATCC® ACS-3004). To make complete NPC medium add the following components of this kit to 250 mL DMEM: F12:

    237 mL DMEM: F12 (Basal medium)
    2.5 mL L-Alanyl-L-Glutamine
    2.5 mL Non-Essential Amino Acids + 0.5 mL Ascrobic Acid
    5 mL Dopa Differentiation Kit Component A
    2.5 mLDopa Differentiation Kit Component B
    0.5 mL  Dopa Differentiation Kit Component C

    For-Profit:   $315.00 Non-Profit:   $315.00

    Preview Product

    Product Format: frozen
    Comments: 2.5 mL L-Alanyl-L-Glutamine
    2.5 mL Non-Essential Amino Acids + 0.5 mL Ascrobic Acid
    5 mL Dopa Differentiation Kit Component A
    2.5 mLDopa Differentiation Kit Component B
    0.5 mL Dopa Differentiation Kit Component C
  • Growth Kit for Neural Progenitor Cell Expansion (ATCC® ACS-3003)

    ATCC® Number: ACS-3003
    Storage: -20⁰C.
    Applications:

    The media is specially designed for expansion of iPSC-derived neural progenitor cells (NPCs).

    Complete growth media for NPCs is DMEM: F12 (ATCC® 30-2006; not included) supplemented with the Growth Kit for Neural Progenitor Cell Expansion (ATCC® ACS-3003). To make complete NPC medium add the following components of this kit to 464 mL DMEM: F12:

    5 mL L-Alanyl-L-Glutamine
    5 mL Non-Essential Amino Acids
    10 mL NPC Growth Kit Component A
    5 mL NPC Growth Kit Component B
    1 mL NPC Growth Kit Component C
    10 mL NPC Growth Kit Component D

    For-Profit:   $310.00 Non-Profit:   $310.00

    Preview Product

    Product Format: frozen
    Comments: 5 mL L-Alanyl-L-Glutamine
    5 mL Non-Essential Amino Acids
    10 mL NPC Growth Kit Component A
    5 mL NPC Growth Kit Component B
    1 mL NPC Growth Kit Component C
    10 mL NPC Growth Kit Component D
    Focus Area:

    Neuronal Differentiation And Drug Screening

  • Angio-Ready Screening Fee (for-profit) (ATCC® ACS-2102)

    ATCC® Number: ACS-2102
    Applications:

    The Angio-Ready™ Angiogenesis Assay System is only distributed under the terms of a fully signed and executed ATCC® Material Transfer Agreement and Addendum to ATCC MTA for Angio-Ready Products along with purchase of Angio Ready Screening Fee

    Use of the Angio-Ready Angiogenesis Assay System in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development is subject to a yearly fee with automatic renewal.

    For-Profit:   $5,000.00 Non-Profit:   $5,000.00

    Preview Product

    Comments:

    The Angio-Ready™ Angiogenesis Assay System is only distributed under the terms of a fully signed and executed ATCC® Material Transfer Agreement and Addendum to ATCC MTA for Angio-Ready Products along with purchase of Angio Ready Screening Fee

    Use of the Angio-Ready Angiogenesis Assay System in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development is subject to a yearly fee with automatic renewal.

  • Angio-Ready Screening Fee (not-for-profit) (ATCC® ACS-2101)

    ATCC® Number: ACS-2101
    Applications:

    The Angio-Ready™ Angiogenesis Assay System is only distributed under the terms of a fully signed and executed ATCC® Material Transfer Agreement and Addendum to ATCC MTA for Angio-Ready Products along with purchase of Angio Ready Screening Fee

    Use of the Angio-Ready Angiogenesis Assay System in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development is subject to a yearly fee with automatic renewal.

    For-Profit:   $1,200.00 Non-Profit:   $1,200.00

    Preview Product

  • 1